NovoCure (NVCR) Insider Trading & Ownership → This TSLA short trade is on a nine win hot streak (From WealthPress) (Ad) Free NVCR Stock Alerts $22.32 -0.83 (-3.59%) (As of 05/28/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NovoCure (NASDAQ:NVCR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.29%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$163,632.37 Get NVCR Insider Trade Alerts Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NVCR Insider Buying and Selling by Quarter Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. NovoCure Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/4/2024Frank X LeonardEVPSell840$16.01$13,448.40 3/4/2024Wilhelmus Cm GroenhuysenCOOSell1,217$16.01$19,484.17 3/1/2024Frank X LeonardEVPSell1,679$16.03$26,914.37 3/1/2024Wilhelmus Cm GroenhuysenCOOSell2,107$16.03$33,775.21 2/28/2024Frank X LeonardEVPSell2,078$16.14$33,538.92 11/7/2023Pritesh ShahInsiderSell382$12.65$4,832.30 9/1/2023Ashley CordovaCFOSell883$21.82$19,267.06 9/1/2023Pritesh ShahInsiderSell273$21.82$5,956.86 9/1/2023Wilhelmus Cm GroenhuysenCOOSell294$21.82$6,415.08 (Data available from 1/1/2013 forward) NVCR Insider Trading Activity - Frequently Asked Questions Who is on NovoCure's Insider Roster? The list of insiders at NovoCure includes Asaf Danziger, Ashley Cordova, Ely Benaim, Frank X Leonard, Gabriel Leung, Jeryl L Hilleman, Martin J Madden, Pritesh Shah, Todd Christopher Longsworth, Uri Weinberg, Wilhelmus Cm Groenhuysen, and William F Doyle. Learn more on insiders at NVCR. What percentage of NovoCure stock is owned by insiders? 6.29% of NovoCure stock is owned by insiders. Learn more on NVCR's insider holdings. Which NovoCure insiders have been selling company stock? The following insiders have sold NVCR shares in the last 24 months: Asaf Danziger ($23,107,250.00), Ashley Cordova ($187,106.34), Ely Benaim ($30,441.42), Frank X Leonard ($3,738,212.03), Jeryl L Hilleman ($28,331.27), Pritesh Shah ($10,789.16), Uri Weinberg ($945,728.02), Wilhelmus Cm Groenhuysen ($224,917.50), and William F Doyle ($58,305.42). How much insider selling is happening at NovoCure? Insiders have sold a total of 281,332 NovoCure shares in the last 24 months for a total of $28,331,081.16 sold. More Insider Trading Tools from MarketBeat Related Companies: ICUI Insider Transactions NARI Insider Transactions IART Insider Transactions IRTC Insider Transactions LMAT Insider Transactions TNDM Insider Transactions ATEC Insider Transactions AXNX Insider Transactions PRCT Insider Transactions MDXG Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:NVCR) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWall Street Legend Warns: "A Strange Day Is Coming to America"Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.